Fundraise for What Matters to You
Every participant has the option to fundraise for the specific disease area, program, researcher, or clinician that is the most meaningful to them, or for our areas of cancer research greatest need.
Our Impact
Obliteride accelerates science that changes lives — and the world.
With Obliteride support, science builds on science at Fred Hutch, propelling bold ideas and speeding up urgently needed advances. Over 14 years, we’ve fueled breakthroughs that expand immunotherapy, unlock new precision approaches to care, improve cancer prevention, provide customized support for patients and families, and more. Explore just some of the discovery Obliteride has made possible.
Immunotherapies Are Possible for More People
Fred Hutch is harnessing the immune system to treat more cancers and spark advances in care.
Research Spotlight: Expanding T-Cell Therapy
Obliteride support helped Fred Hutch researchers re-engineer patients' own immune T cells — the body's natural disease fighters — to specifically target and eliminate a form of leukemia. When these “living medicines” worked for some patients but not others, we uncovered how to refine the approach. Now, we are working to expand treatments to more types of cancers, including mesothelioma and ovarian cancer.
What’s next? Fred Hutch is working to translate the successes demonstrated for immunotherapies for blood cancers into new options for solid tumor cancers, understand why some people experience relapse, and advance options to help more people.
“Cancer is complex, but through advances in immunotherapy, we’ve demonstrated that certain kinds are beatable. Now, we’re working to broaden that effect.”
— Aude G. Chapuis, MD, Medical oncologist and immunotherapy researcher; Professor, Fred Hutch and UW Medicine; John C. and Karyl Kay Hughes Foundation Endowed Chair, Fred Hutch
Cancer Care Is More Precise
We’re using fundamental discoveries about how living things grow and function, and each person’s biology, to tailor care and treatment.
Research Spotlight: Liquid Biopsies
Fueled in part by Obliteride, Fred Hutch researchers developed new technologies to understand the basic programming of cancer cells. Now we’re using those discoveries to develop blood tests called liquid biopsies that provide key information about tumors. The tests are less invasive for patients than surgical biopsies and have the potential to revolutionize care by helping detect cancers, monitor treatment, and find early signs of relapse.
What’s next? We are expanding precision oncology approaches to improve outcomes: identifying signals in data that pinpoint risk, finding new targets for therapy, and improving detection.
“Each patient’s cancer is unique, so making accurate, precise diagnoses is critical. We envision expanding our liquid biopsy tests to work with more cancer types and to transform clinical care for even more patients.”
— Gavin Ha, PhD, Computational biologist; Associate Professor, Fred Hutch; Shintaffer Family Endowed Chair in Bioinformatics, Fred Hutch
Research Propels Prevention
Our researchers are unraveling the links between genetics, diet, lifestyle, and environment to understand risk and improve screening and prevention.
Research Spotlight: Genes, Risk, and Detection
We uncovered combinations of changes to our DNA that raise the risk for prostate and colorectal cancers. Patients and care teams can use these “polygenic risk scores” to customize prevention and screening. Our work to stop colon cancer also includes leading an international consortium that examines lifestyle factors and genetic information to better understand who is at higher risk for cancer — and when they should begin screening.
What’s next? We’re empowering individuals and communities by harnessing new tools, including AI and machine learning, to understand risk; addressing the 15% to 20% of cancers caused by viruses and other pathogens; establishing links between diet and health; and more.
“Our goal is more personalized prevention. If we can identify people at higher risk earlier in life, they may benefit from early screening or monitoring. We’re matching the right intervention to the right person at the right time.”
— Li Hsu, PhD, Biostatistician; Professor, Fred Hutch
Science Strengthens Support
Every person’s cancer is unique — and so is their experience. We’re partnering with people who have or have had cancer to address their health and needs during and beyond treatment.
Program Spotlight: Caring for the Whole Person
Fred Hutch provides a wide swath of patient-centered care and services. This support ranges from our Integrative Medicine team, which studies and deploys evidence-based complementary therapies such as acupuncture and mindfulness; to the work of our survivorship program, which focuses on studying and addressing the challenges people face after treatment, to our palliative care and research teams, which provide specialized care and research-based tools that help people begin important conversations and access support.
What’s next? Fred Hutch will continue to work in partnership with people experiencing cancer — before, during, and after treatment — to understand and create tools that support their physical, spiritual, and emotional health.
“Every patient’s story matters. The right resources and planning give every person an opportunity for the best and most meaningful experience. Our goal is to help all our patients have the best quality of life."
— Megan Shen, PhD, Social psychologist and end-of-life care researcher; Associate Professor, Fred Hutch; Deputy Associate Director, Community Outreach and Engagement, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
About Fred Hutch
Fred Hutch Cancer Center is globally recognized for trailblazing discoveries that have helped save more than a million lives worldwide. Based in Seattle, Fred Hutch is the only NCI-designated cancer center in Washington state and is home to Nobel Prize–winning scientists and cancer care experts who have made major breakthroughs in preventing and eliminating cancer and infectious disease — including bone marrow transplantation, immunotherapy and the HPV vaccine. Fred Hutch’s role as a hub for national research initiatives and clinical trial networks helps scale discoveries for greater impact. An independent cancer center, Fred Hutch also serves as UW Medicine’s cancer program. Learn more at FredHutch.org.
For more than 50 years, Fred Hutch has been looking beyond what’s possible today to a new era of discovery. With your partnership, our Campaign for Fred Hutch is transforming the pace and scale of innovation so we can redefine cancer and infectious disease for generations to come.
Fred Hutch Cancer Center is an independent, nonprofit organization that also serves as UW Medicine's cancer program.